ClinicalTrials.Veeva

Menu

Prospective, Randomized Multi-Center Study of Using the Hyper-CL™ Lens in Subjects Suffering From Bacterial Keratitis

E

EyeYon Medical

Status

Completed

Conditions

Bacterial Keratitis

Treatments

Device: Hyper-CL™ lens

Study type

Interventional

Funder types

Industry

Identifiers

NCT03845374
CLI-H004

Details and patient eligibility

About

This study is a prospective, randomized, open-label, two arms, clinical study aim to evaluate the efficacy and safety of treatment with Hyper-CL™ lens + Antibiotics compared with treatment with Antibiotics only, in subjects with Bacterial keratitis.

The design of the Hyper-CL™ lens increases contact time of the antibiotics on the cornea enabling increased bioavailability of the active drug.

Full description

The Hyper-CL™ Therapeutic soft contact lenses for short-term wear (up to 7 days) are indicated for therapeutic use to promote corneal healing and relieve corneal pain by protecting the cornea during the treatment of acute or chronic pathologies, such as corneal edema, corneal erosions, entropion, bullous keratopathy, and corneal dystrophies as well as post-surgical conditions resulting from cataract extraction and corneal surgery.

Enrollment

12 patients

Sex

All

Ages

18 to 86 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Subject is 18-86 years old
  2. Subject with Bacterial keratitis in one eye only
  3. Subject with Bacterial Keratitis of at least grade 2 score in Average length of infiltration and in Average length of epithelial defect (1mm or above)
  4. Best-corrected visual acuity of 6/60 or better in the uninvolved eye
  5. No prior antibiotic treatment for current Bacterial Keratitis
  6. Subject understands the study requirements and the treatment procedures and provides written Informed Consent before any study-specific tests or procedures are performed

Exclusion criteria

  1. Perforation or imminent perforation of cornea
  2. Subject with glaucoma shunts (e.g. Ahmed valve) and or bleb
  3. Sign of inflammation in both eyes
  4. Severe itching suggesting viral infection or allergy reaction
  5. Subepithelial infiltrate suggesting viral infection
  6. Dendrite like ulcer or suspecting of Herpes keratitis
  7. Previous penetrating keratoplasty
  8. No light perception in the affected eye
  9. Pregnancy
  10. Other active ocular infection
  11. Any infiltration suggesting other than bacterial infection e.g. parasite, fungal
  12. Any corneal transplant
  13. Post refractive surgery
  14. Corneal inlays
  15. Any other condition which in the opinion of the investigator would place the patient at undue risk for participation.
  16. Participation in another clinical study within the past 30 days

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

12 participants in 2 patient groups

Conventional Antibiotics+ Hyper-CL™ lens
Experimental group
Description:
Conventional treatment with topical Antibiotics+ Hyper-CL™ lens
Treatment:
Device: Hyper-CL™ lens
Conventional Antibiotics
No Intervention group
Description:
Conventional treatment with topical Antibiotics

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems